Physician profile
Edwin Scott
NPI 1942240437
$2,203.37
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $341 · 2020: $484 · 2021: $944 · 2022: $409 · 2023: $25.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $25.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $25.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $476.21 | 2019-2022 | |
| Amarin Pharma, INC. | $256.87 | 2020-2022 | |
| Astellas Pharma US INC | $203.19 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $174.48 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $116.26 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $115.39 | 2019-2022 | |
| Abbvie INC. | $100.78 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $90.86 | 2021-2022 | |
| Dexcom, INC. | $84.76 | 2022-2023 | Dexcom G6 Transmitter |
| Novartis Pharmaceuticals Corporation | $79.48 | 2019-2022 | |
| Lilly USA, LLC | $73.14 | 2019-2022 | |
| Boston Scientific Corporation | $72.69 | 2021 | |
| Sanofi-Aventis U.S. LLC | $64.52 | 2021-2022 | |
| Pfizer INC. | $41.45 | 2020-2022 | |
| Amgen INC. | $37.89 | 2019-2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $28.75 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $26.79 | 2019-2020 | |
| Abbott Laboratories | $26.66 | 2021 | |
| Glaxosmithkline, LLC. | $25.19 | 2021 | |
| Allergan, INC. | $24.79 | 2020 | |
| Alkermes, INC. | $22.51 | 2022 | |
| Esperion Therapeutics, INC. | $18.52 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $14.62 | 2022 | |
| Jazz Pharmaceuticals INC. | $13.87 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $13.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edwin Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.